Geode Capital Management
PLYX

Geode Capital Management’s Polaryx Therapeutics Inc PLYX Stock Holding History

Geode Capital Management’s Portfolio PLYX Stock Details PLYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Buy
170,998
+325
+0.2% +$1.27K ﹤0.01% 3643
2026
Q1 		$1.29M Buy
+170,673
New +$1.1M ﹤0.01% 3283

Other funds holding PLYX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AF
Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return
Vanguard Global Advisers
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Geode Capital Management's PLYX Position: Q2 2026 in Review

Geode Capital Management increased its Polaryx Therapeutics Inc (PLYX) stake by 0.19% in Q2 2026, buying an estimated $1.27K and bringing the position to 170,998 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #3643.

Geode Capital Management first reported a position in PLYX in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.29M in Q1 2026. 13 funds tracked by Wall St. Rank hold PLYX as of Q2 2026.

  • Geode Capital Management held 170,998 shares of Polaryx Therapeutics Inc worth $455K as of Q2 2026.
  • Geode Capital Management bought 325 Polaryx Therapeutics Inc shares in Q2 2026, an estimated $1.27K.
  • Polaryx Therapeutics Inc made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3643 holding.
  • Geode Capital Management first reported a position in Polaryx Therapeutics Inc in Q1 2026 and has held it in 2 quarters since.
  • Geode Capital Management's Polaryx Therapeutics Inc position peaked at $1.29M in Q1 2026.
  • 13 funds tracked by Wall St. Rank held Polaryx Therapeutics Inc as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.